Antifungal efficacy of scorpion derived peptide K1K8 against Candida albicans in vitro and in vivo.

As an alternative class of antimicrobial agents, antimicrobial peptides (AMPs) have gained significant attention. In this study, K1K8, a scorpion AMP derivative, showed effective activity against Candida albicans including clinically resistant strains. K1K8 killed C. albicans cells mainly by damaging the cell membrane and inducing necrosis via an ROS-related pathway. K1K8 could also interact with DNA after damaging the nuclear envelope. Moreover, K1K8 inhibited hyphal development and biofilm formation of C. albicans in a dose-dependent manner. In the mouse skin infection model, K1K8 significantly decreased the counts of C. albicans cells in the infection area. Overall, K1K8 is a potential anti-infective agent against skin infections caused by C. albicans. [Display omitted] • K1K8 showed effective activity against Candida albicans in vitro. • K1K8 damaged the cell membrane, induced necrosis, and interacted with DNA. • K1K8 inhibited hyphal development and biofilm formation of C. albicans. • K1K8 effectively inhibited C. albicans in a mouse skin infection model. • K1K8 is a potential anti-infective agent against skin infections caused by C. albicans. [ABSTRACT FROM AUTHOR]